Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations
Sign Up to like & getrecommendations! Published in 2022 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.14685
Abstract: As the number of genetic mutations that must be tested increases, the Oncomine Dx Target test (ODxTT), which can simultaneously detect multiple cancer‐related genes is becoming the main test used in preference to single‐molecule testing.… read more here.
Keywords: detecting egfr; egfr mutation; test; mutation test ... See more keywords
Possible False Results With cobas® EGFR Mutation Test v2 and Oncomine Dx Target Test for EGFR Mutation
Sign Up to like & getrecommendations! Published in 2023 at "AntiCancer Research"
DOI: 10.21873/anticanres.16445
Abstract: Background/Aim: Disparities in the results of next-generation sequencing-based multiplex gene panel tests and those of single-gene tests when detecting epidermal growth factor receptor (EGFR) mutations in non-small-cell lung cancer (NSCLC) have been reported. However, the… read more here.
Keywords: egfr mutation; test; cobas egfr; false results ... See more keywords